| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1006495203 |
| P356 | DOI | 10.1186/AR1478 |
| P932 | PMC publication ID | 1064899 |
| P698 | PubMed publication ID | 15642151 |
| P5875 | ResearchGate publication ID | 8089482 |
| P50 | author | Marije Koenders | Q38318056 |
| P2093 | author name string | Wim B van den Berg | |
| Erik Lubberts | |||
| P2860 | cites work | Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family | Q22011116 |
| IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1 | Q24290462 | ||
| IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding | Q24291729 | ||
| Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production | Q24291773 | ||
| Human IL-17: a novel cytokine derived from T cells | Q24304404 | ||
| Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 | ||
| CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene | Q24315956 | ||
| IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis | Q24563235 | ||
| RANK is essential for osteoclast and lymph node development | Q24598872 | ||
| Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction | Q24676400 | ||
| T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines | Q24678115 | ||
| Expression, modulation and signalling of IL-17 receptor in fibroblast-like synoviocytes of patients with rheumatoid arthritis | Q24681298 | ||
| IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis | Q24796707 | ||
| Anti-cytokine therapy in chronic destructive arthritis | Q24805245 | ||
| A novel cytokine receptor-ligand pair. Identification, molecular characterization, and in vivo immunomodulatory activity | Q28119212 | ||
| Interleukin-17 family and IL-17 receptors | Q28185677 | ||
| Forced expression of murine IL-17E induces growth retardation, jaundice, a Th2-biased response, and multiorgan inflammation in mice | Q28206221 | ||
| Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis | Q28208761 | ||
| Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17 | Q28213628 | ||
| IL-17: prototype member of an emerging cytokine family | Q28214946 | ||
| Elastase and cathepsin G of human monocytes. Quantification of cellular content, release in response to stimuli, and heterogeneity in elastase-mediated proteolytic activity | Q28272534 | ||
| OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 | ||
| New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25 | Q28592257 | ||
| Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor | Q28609151 | ||
| Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation | Q29614224 | ||
| Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain | Q29614225 | ||
| Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis | Q29620481 | ||
| Increased expression of interleukin 17 in inflammatory bowel disease | Q29622829 | ||
| Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. | Q33740453 | ||
| Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis | Q33908167 | ||
| Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense | Q34087551 | ||
| Soluble and transmembrane isoforms of novel interleukin-17 receptor-like protein by RNA splicing and expression in prostate cancer. | Q34101525 | ||
| Mouse IL-17: a cytokine preferentially expressed by alpha beta TCR + CD4-CD8-T cells | Q34403468 | ||
| Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB. | Q34474493 | ||
| Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways | Q34492076 | ||
| IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist | Q35022575 | ||
| IL-17-induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen-activated protein (MAP) kinases | Q35043470 | ||
| Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy | Q35083970 | ||
| The role of IL-17 and family members in the pathogenesis of arthritis | Q35165972 | ||
| Effect of interleukin 17 on proteoglycan degradation in murine knee joints | Q35549425 | ||
| Interleukin 17 synergises with tumour necrosis factor alpha to induce cartilage destruction in vitro | Q35551055 | ||
| IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion | Q37202023 | ||
| Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion | Q40590532 | ||
| IL-17 regulates gene expression and protein synthesis of the complement system, C3 and factor B, in skin fibroblasts | Q40887975 | ||
| NF-kappa B-inducing kinase is a common mediator of IL-17-, TNF-alpha-, and IL-1 beta-induced chemokine promoter activation in intestinal epithelial cells | Q40956645 | ||
| Elastase secreted by activated polymorphonuclear leucocytes causes chondrocyte damage and matrix degradation in intact articular cartilage: escape from inactivation by alpha-1-proteinase inhibitor. | Q41557458 | ||
| Interleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokines | Q41866942 | ||
| Interleukin-17: A new bone acting cytokine in vitro | Q42476956 | ||
| Reduction of interleukin-17-induced inhibition of chondrocyte proteoglycan synthesis in intact murine articular cartilage by interleukin-4. | Q42489307 | ||
| Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci | Q42511137 | ||
| Interleukin 17 (IL-17) induces collagenase-3 production in human osteoarthritic chondrocytes via AP-1 dependent activation: differential activation of AP-1 members by IL-17 and IL-1beta | Q42522382 | ||
| Compromised humoral and delayed-type hypersensitivity responses in IL-23-deficient mice | Q42620442 | ||
| IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines | Q42824130 | ||
| Overexpression of IL-17 in the knee joint of collagen type II immunized mice promotes collagen arthritis and aggravates joint destruction | Q43945860 | ||
| Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses | Q44158655 | ||
| Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. | Q47909675 | ||
| Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions | Q50232370 | ||
| IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. | Q51687384 | ||
| Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. | Q52032586 | ||
| Microbial lipopeptides induce the production of IL-17 in Th cells. | Q52968185 | ||
| IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance | Q64378013 | ||
| IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis | Q64379692 | ||
| Mitogen-activated protein kinase and nuclear factor kappaB together regulate interleukin-17-induced nitric oxide production in human osteoarthritic chondrocytes: possible role of transactivating factor mitogen-activated protein kinase-activated prot | Q73165868 | ||
| Increased interleukin-17 production in patients with systemic sclerosis | Q73202422 | ||
| Interleukin-17 up-regulation of nitric oxide production in human osteoarthritis cartilage | Q73414178 | ||
| High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism | Q73458527 | ||
| Cell-cell contact of human T cells with fibroblasts changes lymphocytic mRNA expression: increased mRNA expression of interleukin-17 and interleukin-17 receptor | Q73516728 | ||
| Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytes | Q73969172 | ||
| Expression of IL-17 mRNA in ovarian cancer | Q74008184 | ||
| The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model | Q74024097 | ||
| IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages | Q74412124 | ||
| Interleukin-17 enhances tumor necrosis factor alpha-induced synthesis of interleukins 1,6, and 8 in skin and synovial fibroblasts: a possible role as a "fine-tuning cytokine" in inflammation processes | Q74602889 | ||
| Pathways by which interleukin 17 induces articular cartilage breakdown in vitro and in vivo | Q74829119 | ||
| Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium | Q77738643 | ||
| Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors | Q77787649 | ||
| Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion protein | Q77838768 | ||
| IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells | Q78109562 | ||
| Interleukin-17 promotes angiogenesis and tumor growth | Q78460523 | ||
| Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice | Q79317500 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell | Q7868 |
| peptide | Q172847 | ||
| rheumatoid arthritis | Q187255 | ||
| interleukins | Q194908 | ||
| biomedical investigative technique | Q66648976 | ||
| hemic and immune systems | Q70202933 | ||
| P304 | page(s) | 29-37 | |
| P577 | publication date | 2004-11-30 | |
| P1433 | published in | Arthritis Research and Therapy | Q15757229 |
| P1476 | title | The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models | |
| P478 | volume | 7 |
| Q26852836 | Acquiring chondrocyte phenotype from human mesenchymal stem cells under inflammatory conditions |
| Q45991876 | All-trans retinoic acid down-regulates inflammatory responses by shifting the Treg/Th17 profile in human ulcerative and murine colitis. |
| Q35804523 | An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals |
| Q90720534 | Andrographolide Ameliorates Rheumatoid Arthritis by Regulating the Apoptosis-NETosis Balance of Neutrophils |
| Q58998247 | Anti IL-17A therapy inhibits bone loss in TNF-α-mediated murine arthritis by modulation of the T-cell balance |
| Q35228585 | Anti-arthritic activity of Fu-Fang-Lu-Jiao-Shuang on collagen-induced arthritis in Balb/c mice and its underlying mechanisms |
| Q33737485 | Anti-inflammatory effects of licorice and roasted licorice extracts on TPA-induced acute inflammation and collagen-induced arthritis in mice |
| Q39906208 | Anticytokine therapy for osteoarthritis: evidence to date |
| Q42917641 | Association analysis of the interleukin 17 genes IL17A and IL17F as potential osteoarthritis susceptibility loci |
| Q46193783 | Association between severity of knee osteoarthritis and serum and synovial fluid interleukin 17 concentrations |
| Q39320174 | Autoreactive Th1 cells activate monocytes to support regional Th17 responses in inflammatory arthritis |
| Q35067840 | B cells contribute to heterogeneity of IL-17 producing cells in rheumatoid arthritis and healthy controls |
| Q35915683 | Bifunctional Peptide Inhibitors Suppress Interleukin-6 Proliferation and Ameliorates Murine Collagen-Induced Arthritis |
| Q27308865 | Bio-imaging and Photodynamic Therapy with Tetra Sulphonatophenyl Porphyrin (TSPP)-TiO2 Nanowhiskers: New Approaches in Rheumatoid Arthritis Theranostics |
| Q37334114 | Biological agents targeting beyond TNF-alpha |
| Q37420222 | CP-690550 Treatment Ameliorates Established Disease and Provides Long-Term Therapeutic Effects in an SKG Arthritis Model |
| Q37270714 | Cartilage homeostasis in health and rheumatic diseases |
| Q35157851 | Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice |
| Q37000837 | Cells of the synovium in rheumatoid arthritis. Chondrocytes |
| Q35769049 | Cells of the synovium in rheumatoid arthritis. T lymphocytes. |
| Q39308974 | Cellular and molecular perspectives in rheumatoid arthritis |
| Q84021987 | Cholecystokinin octapeptide exerts its therapeutic effects on collagen-induced arthritis by suppressing both inflammatory and Th17 responses |
| Q37047867 | Chronic pediatric inflammatory diseases: effects on bone |
| Q35231468 | Commercial cow milk contains physically stable extracellular vesicles expressing immunoregulatory TGF-β. |
| Q40054411 | Commercial peptidoglycan preparations are contaminated with superantigen-like activity that stimulates IL-17 production |
| Q37987351 | Current understanding of rheumatoid arthritis therapy |
| Q34279737 | Cutting edge: identification of a pre-ligand assembly domain (PLAD) and ligand binding site in the IL-17 receptor |
| Q36577367 | Cytokine networks--towards new therapies for rheumatoid arthritis |
| Q34252489 | Cytokine-mediated bone destruction in rheumatoid arthritis |
| Q28303865 | Cytokines in the pathogenesis of rheumatoid arthritis |
| Q36245722 | Cytokines profiling by multiplex analysis in experimental arthritis: which pathophysiological relevance for articular versus systemic mediators? |
| Q37627969 | Cytotoxic T cells modulate inflammation and endogenous opioid analgesia in chronic arthritis |
| Q92404733 | Daurinol Attenuates Autoimmune Arthritis via Stabilization of Nrp1-PTEN-Foxp3 Signaling in Regulatory T Cells |
| Q35907743 | Depletion of regulatory T cells leads to an exacerbation of delayed-type hypersensitivity arthritis in C57BL/6 mice that can be counteracted by IL-17 blockade |
| Q36808811 | Development of proteoglycan-induced arthritis is independent of IL-17. |
| Q53308503 | Different Blood-Borne Human Osteoclast Precursors Respond in Distinct Ways to IL-17A. |
| Q42216422 | Differential requirement for P2X7R function in IL-17 dependent vs. IL-17 independent cellular immune responses |
| Q24674584 | Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression |
| Q80545112 | Distinct in vivo roles of CD80 and CD86 in the effector T-cell responses inducing antigen-induced arthritis |
| Q42558375 | Effector mechanisms of interleukin-17 in collagen-induced arthritis in the absence of interferon-gamma and counteraction by interferon-gamma. |
| Q47983201 | Effects of glucocorticoid treatment on CD25⁻FOXP3⁺ population and cytokine-producing cells in rheumatoid arthritis. |
| Q42845326 | Effects of low-dose-gamma rays on the immune system of different animal models of disease |
| Q40823594 | Elevated autoantibodies against interleukin-17F correlate with disease activity in patients with early rheumatoid arthritis |
| Q37739800 | Ellagic acid alleviates adjuvant induced arthritis by modulation of pro- and anti-inflammatory cytokines |
| Q37340457 | Emerging applications of anticytokine vaccines |
| Q36835533 | Emerging targets of biologic therapies for rheumatoid arthritis |
| Q33784120 | Estrogen enhances the functions of CD4(+)CD25(+)Foxp3(+) regulatory T cells that suppress osteoclast differentiation and bone resorption in vitro |
| Q37316594 | Evidence that cytokines play a role in rheumatoid arthritis |
| Q37206604 | Exacerbated inflammatory arthritis in response to hyperactive gp130 signalling is independent of IL-17A. |
| Q36697550 | Experimental rodent models of prostatitis: limitations and potential |
| Q37951686 | Exploring the biological basis of haemophilic joint disease: experimental studies |
| Q82209428 | Flk-1+ mesenchymal stem cells aggravate collagen-induced arthritis by up-regulating interleukin-6 |
| Q44781663 | Frequencies of circulating IL-17-producing CD4+CD161+ T cells and CD4+CD161+ T cells correlate with disease activity in rheumatoid arthritis |
| Q38491174 | Gene expression profile of the hippocampus of rats subjected to chronic immobilization stress |
| Q46614093 | Genes Critical for Developing Periodontitis: Lessons from Mouse Models |
| Q35585748 | Glucocorticoid therapy of antigen-induced arthritis depends on the dimerized glucocorticoid receptor in T cells |
| Q53455403 | Grape seed proanthocyanidin extract (GSPE) differentially regulates Foxp3+ regulatory and IL-17+ pathogenic T cell in autoimmune arthritis |
| Q35562936 | High-density lipoprotein attenuates Th1 and th17 autoimmune responses by modulating dendritic cell maturation and function |
| Q61651896 | IL-17 in the immunopathogenesis of spondyloarthritis |
| Q41890076 | IL-17 in the rheumatologist's line of sight |
| Q33610883 | IL-17 induces monocyte migration in rheumatoid arthritis |
| Q37184922 | IL-17 induces the production of IL-16 in rheumatoid arthritis |
| Q34591831 | IL-17-mediated Bcl-2 expression regulates survival of fibroblast-like synoviocytes in rheumatoid arthritis through STAT3 activation |
| Q33807584 | IL-17-mediated monocyte migration occurs partially through CC chemokine ligand 2/monocyte chemoattractant protein-1 induction |
| Q37852203 | IL-17A Is Proatherogenic in High-Fat Diet-Induced and Chlamydia pneumoniae Infection-Accelerated Atherosclerosis in Mice |
| Q24294661 | IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats |
| Q28249077 | IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells |
| Q40263019 | Identification of common transcriptional regulatory elements in interleukin-17 target genes |
| Q53543785 | In vitro evaluation of effects of sustained anti-TNF release from MPEG-PCL-MPEG and PCL microspheres on human rheumatoid arthritis synoviocytes. |
| Q37258251 | In vivo action of IL-27: reciprocal regulation of Th17 and Treg cells in collagen-induced arthritis |
| Q36908127 | Increased expression of activation-induced cytidine deaminase is associated with anti-CCP and rheumatoid factor in rheumatoid arthritis |
| Q37316252 | Induction of Th17 lymphocytes and Treg cells by monocyte-derived dendritic cells in patients with rheumatoid arthritis and systemic lupus erythematosus |
| Q36463967 | Influence of infliximab on cytokines network and markers of bone remodeling in rheumatoid arthritis patients |
| Q34656577 | Inhibiting cardiac allograft rejection with interleukin-35 therapy combined with decitabine treatment in mice |
| Q34729932 | Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice |
| Q39612560 | Interleukin-15 induces interleukin-17 production by synovial T cell lines from patients with rheumatoid arthritis |
| Q91900500 | Interleukin-17 suppresses grass carp reovirus infection in Ctenopharyngodon idellus kidney cells by activating NF-κB signaling |
| Q36835789 | Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy |
| Q58133794 | Interleukin-17A Levels Increase in Serum of Children With Juvenile Idiopathic Arthritis |
| Q54470592 | Interleukin-2/anti-interleukin-2 monoclonal antibody immune complex suppresses collagen-induced arthritis in mice by fortifying interleukin-2/STAT5 signalling pathways. |
| Q41201554 | Interleukin-23 is critical for full-blown expression of a non-autoimmune destructive arthritis and regulates interleukin-17A and RORgammat in gammadelta T cells |
| Q37276852 | Interplay between effector Th17 and regulatory T cells |
| Q37350865 | Is there a feudal hierarchy amongst regulatory immune cells? More than just Tregs |
| Q52655388 | Kaempferol targeting on the fibroblast growth factor receptor 3-ribosomal S6 kinase 2 signaling axis prevents the development of rheumatoid arthritis. |
| Q47692110 | Kynurenic acid downregulates IL-17/1L-23 axis in vitro |
| Q33687116 | Linking power Doppler ultrasound to the presence of th17 cells in the rheumatoid arthritis joint |
| Q30484091 | Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis |
| Q35046582 | Local expression of interleukin-27 ameliorates collagen-induced arthritis |
| Q37118786 | Lymphocyte-derived cytokines in inflammatory arthritis. |
| Q37632332 | Major involvement of bacterial components in rheumatoid arthritis and its accompanying oxidative stress, systemic inflammation and hypercoagulability |
| Q35091092 | MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis |
| Q33258042 | Novel insights in the regulation of CCL18 secretion by monocytes and dendritic cells via cytokines, toll-like receptors and rheumatoid synovial fluid |
| Q53527649 | Oral administration of apple condensed tannins delays rheumatoid arthritis development in mice via downregulation of T helper 17 (Th17) cell responses. |
| Q36911794 | Osteoimmunology: from mice to humans |
| Q52597639 | PKCδ-Mediated Nox2 Activation Promotes Fluid-Phase Pinocytosis of Antigens by Immature Dendritic Cells. |
| Q37695081 | Parasitic helminths: new weapons against immunological disorders |
| Q36956216 | Pathologic finding of increased expression of interleukin-17 in the synovial tissue of rheumatoid arthritis patients |
| Q42914259 | Pathways for interleukin-1-driven arthritis |
| Q104135137 | Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis |
| Q35760186 | Pharmacologic repression of retinoic acid receptor-related orphan nuclear receptor γ is therapeutic in the collagen-induced arthritis experimental model |
| Q34274075 | Pharmacotherapy for uveitis: current management and emerging therapy |
| Q35617594 | Positive regulators of osteoclastogenesis and bone resorption in rheumatoid arthritis |
| Q41208723 | Possible Involvement of Liver Resident Macrophages (Kupffer Cells) in the Pathogenesis of Both Intrahepatic and Extrahepatic Inflammation |
| Q54224169 | Prostaglandin E2 and IL-23 interconnects STAT3 and RoRγ pathways to initiate Th17 CD4+ T-cell development during rheumatoid arthritis. |
| Q28586710 | Prostaglandin mediates IL-23/IL-17-induced neutrophil migration in inflammation by inhibiting IL-12 and IFNgamma production |
| Q49629345 | Protective effect of norcantharidin on collagen-induced arthritis rats |
| Q34414983 | RORs in autoimmune disease |
| Q38438986 | Rebamipide suppresses collagen-induced arthritis through reciprocal regulation of th17/treg cell differentiation and heme oxygenase 1 induction |
| Q36757047 | Recent developments in the immunobiology of rheumatoid arthritis |
| Q37350948 | Reduced Fas ligand-expressing splenic CD5+ B lymphocytes in severe collagen-induced arthritis. |
| Q55226585 | Regulation of Osteoclast Differentiation by Cytokine Networks. |
| Q36018275 | Regulatory T cell-mediated anti-inflammatory effects promote successful tissue repair in both indirect and direct manners |
| Q53658913 | Regulatory effect of nicotine on collagen-induced arthritis and on the induction and function of in vitro-cultured Th17 cells. |
| Q51082282 | Relation between bone mineral density and IL-17 serum levels in Serbian patients with early Rheumatoid arthritis. |
| Q84778300 | Repeated Gamma Irradiation Attenuates Collagen-Induced Arthritis via Up-regulation of Regulatory T Cells but not by Damaging Lymphocytes Directly |
| Q28302355 | Retinoid-related orphan receptor gamma t is a potential therapeutic target for controlling inflammatory autoimmunity |
| Q36324975 | Rheumatic diseases: the effects of inflammation on bone |
| Q34595120 | Secondary osteoporosis in patients with juvenile idiopathic arthritis |
| Q46750795 | Secukinumab in Active Rheumatoid Arthritis after Anti-TNFα Therapy: A Randomized, Double-Blind Placebo-Controlled Phase 3 Study |
| Q46008678 | Serum amyloid A protein stimulates CCL20 production in rheumatoid synoviocytes. |
| Q84847776 | Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA |
| Q38425628 | Serum levels of IL-17, IL-4, and INFγ in Serbian patients with early rheumatoid arthritis |
| Q55347406 | Sialylated Autoantigen-Reactive IgG Antibodies Attenuate Disease Development in Autoimmune Mouse Models of Lupus Nephritis and Rheumatoid Arthritis. |
| Q46011580 | Structural, cellular, and molecular evaluation of bone erosion in experimental models of rheumatoid arthritis: assessment by μCT, histology, and serum biomarkers. |
| Q37051768 | Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy |
| Q48158770 | Synovial Fibroblasts Selectively Suppress Th1 Cell Responses through IDO1-Mediated Tryptophan Catabolism. |
| Q37866683 | Synovitis in psoriatic arthritis: immunohistochemistry, comparisons with rheumatoid arthritis, and effects of therapy |
| Q37129568 | T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis |
| Q36667205 | T-bet deficiency attenuates renal injury in experimental crescentic glomerulonephritis. |
| Q36955309 | TH-17 cells in rheumatoid arthritis |
| Q37106521 | TNF-alpha stimulation inhibits siRNA-mediated RNA interference through a mechanism involving poly-(A) tail stabilization. |
| Q38131960 | Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritis |
| Q38344543 | Th17 cells in autoimmune diseases |
| Q35820734 | Th17 cells in human disease. |
| Q37686348 | Th17 cytokines and arthritis |
| Q41161406 | Th17 in Animal Models of Rheumatoid Arthritis |
| Q36801049 | The Development of Novel Therapies for Rheumatoid Arthritis |
| Q36617097 | The IL-17 cytokine family. |
| Q38439641 | The IL-23-IL-17 axis in inflammatory arthritis |
| Q26774681 | The Interplay Between Monocytes/Macrophages and CD4(+) T Cell Subsets in Rheumatoid Arthritis |
| Q37052226 | The Interplay between the bone and the immune system |
| Q38379550 | The Role of T Helper 17 Cells and Other IL-17-Producing Cells in Bone Resorption and Remodeling |
| Q53563550 | The clinical role of IL-23p19 in patients with rheumatoid arthritis. |
| Q39146450 | The contrasting roles of Th17 immunity in human health and disease |
| Q82341302 | The effects of PDL-Ig on collagen-induced arthritis |
| Q43494262 | The evolving systemic and local biomarker milieu at different stages of disease progression in rat adjuvant-induced arthritis |
| Q38134127 | The immune system and postmenopausal osteoporosis. |
| Q37631369 | The inflammatory role of phagocyte apoptotic pathways in rheumatic diseases. |
| Q38529525 | The interleukin (IL)-23/IL-17 axis in ankylosing spondylitis: new advances and potentials for treatment |
| Q37760665 | The multiple faces of CXCL12 (SDF-1alpha) in the regulation of immunity during health and disease |
| Q38050401 | The multiple facets of glucocorticoid action in rheumatoid arthritis |
| Q47684756 | The peroxisome proliferator-activated receptor γ agonist pioglitazone preserves bone microarchitecture in experimental arthritis by reducing the interleukin-17-dependent osteoclastogenic pathway |
| Q36747499 | The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease |
| Q39350335 | Therapeutic effects of a novel tylophorine analog, NK-007, on collagen-induced arthritis through suppressing tumor necrosis factor α production and Th17 cell differentiation |
| Q36395829 | Trauma-induced heterotopic bone formation and the role of the immune system: A review |
| Q86340489 | Treatment of CIA Mice with FGF21 Down-regulates TH17-IL-17 Axis |
| Q30882988 | Tumor-like stem cells derived from human keloid are governed by the inflammatory niche driven by IL-17/IL-6 axis |
| Q38200925 | Tumour necrosis factor α antagonists in the treatment of rheumatoid arthritis: an immunological perspective |
| Q37694304 | Update on Targets of Biologic Therapies for Rheumatoid Arthritis. |
| Q64102242 | Updates on Osteoimmunology: What's New on the Cross-Talk Between Bone and Immune System |
| Q35174915 | Vitamin D deficiency, interleukin 17, and vascular function in rheumatoid arthritis |
| Q37842638 | What can the periodontal community learn from the pathophysiology of rheumatoid arthritis? |
| Q39438071 | Yin and yang of interleukin-17 in host immunity to infection |
| Q52920821 | [Expression analyses for rheumatoid arthritis]. |
| Q87840407 | [Inflammation and bone metabolism] |
| Q80430167 | [Intracellular signaling pathways of synovial fibroblasts in rheumatoid arthritis] |
| Q81261704 | [Pathogenesis of RA: more than just immune cells] |
Search more.